Nuestros recursos

ASD is a heterogeneous clinical condition, which makes it challenging to obtain clinical trial evidence for a targeted therapy. A biotech company aims to break down the one-size-fits-all approach to treating ASD and is seeking data to validate a more targeted strategy.

A pharmaceutical company needed to understand the efficacy and tolerability of a pain relief drug in post-operative and non-surgical patients with moderate to severe pain. The sponsor needed to capture data from both hospitalized and out-patient participants.

A global pharmaceutical company needed to understand the impact of a dissociative anesthetic on quality of life in patients with treatment-resistant depression. The company sought a way to gather high-quality data and carefully monitor suicidality. 

Our APAC partnership with Oracle Life Sciences has been a huge success. Now, we're going global.

AI, patient advocacy groups, digital health technologies, and more. Here’s everything you need to know about the clinical trial trends of 2024—and how they’re reshaping the industry.

This latest offering combines scientific advisory with a no-code study design platform and virtual site to deliver more robust outcomes—and stronger therapeutic evidence—for clinical trial sponsors.

In this webinar, experts from ObvioHealth, Oracle, and PPD provide key insights for driving operational efficiencies and successfully streamlining multisource data sets into a consolidated and actionable source of truth—all to remove burden from the clinical continuum and deliver tomorrow’s powerful insights.

ObvioHealth's partnership with Chemist Warehouse will provide sponsors with a solution for overcoming their biggest roadblock: finding and enrolling the right patients.